[1]贺琼,薄佳琪,张佳鑫,等.扫描式葡萄糖监测技术在2型糖尿病患者血糖管理模式中的应用[J].国际内分泌代谢杂志,2021,41(04):348-351，371.[doi:10.3760/cma.j.cn121383-20200717-07042]
　He Qiong,Bo Jiaqi,Zhang Jiaxin,et al.Application of flash glucose monitoring techology in blood glucose management mode of type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2021,41(04):348-351，371.[doi:10.3760/cma.j.cn121383-20200717-07042]
点击复制

扫描式葡萄糖监测技术在2型糖尿病患者血糖管理模式中的应用()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
41
期数:
2021年04期
页码:
348-351，371
栏目:
综述
出版日期:
2021-07-20

文章信息/Info

Title:
Application of flash glucose monitoring techology in blood glucose management mode of type 2 diabetic patients
作者:
贺琼1; 2; 薄佳琪2; 3; 张佳鑫1; 2; 李捷1; 2; 刘子昂4; 5; 尹建红1; 杨静1; 刘云峰1
1山西医科大学第一医院内分泌科,太原 030001; 2山西医科大学第一临床医学院,太原 030001; 3山西医科大学第一医院消化内科,太原 030001; 4山西省白求恩医院(山西医学科学院),太原 030001; 5山西医科大学第三临床医学院,太原 030001
Author(s):
He Qiong1; 2;  Bo Jiaqi2; 3;  Zhang Jiaxin1; 2;  Li Jie1; 2;  Liu Ziang4; 5;  Yin Jianhong1;  Yang Jing1;  Liu Yunfeng1.
1Department of Endocrinology, the First Hospital of Shanxi Medical University, Taiyuan 030001, China; 2The First Clinical School, Shanxi Medical University, Taiyuan 030001, China; 3Department of Gastroenterology and Hepatology, the First Hospital of Shanxi Medical University, Taiyuan 030001, China; 4Shanxi Bethune Hospital & Shanxi Academy of Medical Sciences, Taiyuan 030001, China; 5The Third Clinical School, Shanxi Medical University, Taiyuan 030001, China
关键词:
扫描式葡萄糖监测;  2型糖尿病;  血糖管理
Keywords:
Flash glucose monitoring;  Type 2 diabetes mellitus;  Blood glucose management
DOI:
10.3760/cma.j.cn121383-20200717-07042
摘要:
扫描式葡萄糖监测(FGM)正改变着糖尿病患者血糖监测技术的格局。在2型糖尿病(T2DM)患者中,接受强化治疗和自我血糖监测下仍有严重低/高血糖或血糖波动大的T2DM患者是FGM受众群体中的重要组成部分。FGM技术革新性完全颠覆了传统指尖采血测定葡萄糖的管理模式。但目前国内外均无针对使用FGM的T2DM患者统一血糖管理模式的规范,临床应用中这一领域较为混乱。现结合实际工作经验,参考临床试验和指南推荐条目,试讨论使用FGM的T2DM患者的规范血糖管理模式,以期规范临床使用,发挥FGM对T2DM患者血糖监测的优势。
Abstract:
Flash glucose monitoring(FGM)is changing the pattern of blood glucose monitoring technology for diabetic patients. Among patients with type 2 diabetes mellitus(T2DM), T2DM patients with severe hypo/hyperglycemia or large blood glucose fluctuations under intensive treatment and self-monitoring of blood glucose are important parts of the FGM accepters. The innovation of FGM technology has completely subverted the traditional management model of fingertip blood sampling to determine glucose. However, there is currently no unified blood glucose management model for T2DM patients who use FGM at home and abroad, and this field is rather chaotic in clinical applications. This review combines our actual experience, results of clinical trials and recommended items in the guidelines, trying to discuss the standardized blood glucose management mode of T2DM patients using FGM, standardize clinical use and give full play to the advantages of FGM in blood glucose monitoring of T2DM patients.

参考文献/References:

[1] 中华医学会糖尿病学分会血糖监测学组.中国扫描式葡萄糖监测技术临床应用专家共识 [J].中华糖尿病杂志,2018,10(11):697-700.DOI:10.3760/cma.j.issn.1674-5809.2018.11.001.
[2] Saeedi P,Petersohn I,Salpea P,et al.IDF Diabetes Atlas Committee.Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045:results from the International Diabetes Federation Diabetes Atlas,9(th)edition [J].Diabetes Res Clin Pract,2019,157:107843.DOI:10.1016/j.diabres.2019.107843.
[3] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中华糖尿病杂志,2014,7:447-498.DOI:10.3760/cma.j.issn.1674-5809.2014.07.004.
[4] Wada E,Onoue T,Kobayashi T,et al.Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes:a randomized controlled trial [J].BMJ Open Diabetes Res Care,2020,8(1):e001115 DOI:10.1136/bmjdrc-2019-001115.
[5] Haak T,Hanaire H,Ajjan R,et al.Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes:a multicenter,open-label randomized controlled trial [J].Diabetes Ther,2017,8(1):55-73.DOI:10.1007/s13300-016-0223-6.
[6] Hommel E,Olsen B,Battelino T,et al.Impact of continuous glucose monitoring on quality of life,treatment satisfaction,and use of medical care resources:analyses from the SWITCH study [J].Acta Diabetol,2014,51(5):845-851.DOI:10.1007/s00592-014-0598-7.
[7] Chamberlain JJ,Dopita D,Gilgen E,et al.Impact of frequent and persistent use of continuous glucose monitoring(CGM)on hypoglycemia fear,frequency of emergency medical treatment,and SMBG frequency after one year [J].J Diabetes Sci Technol,2015,10(2):383-388.DOI:10.1177/1932296815604633.
[8] Borot S,Benhamou PY,Atlan C,et al.Practical implementation,education and interpretation guidelines for continuous glucose monitoring:a french position statement [J].Diabetes Metab,2018,44(1):61-72.DOI:10.1016/j.diabet.2017.10.009.
[9] Messer L,Ruedy K,Xing D,et al.Educating families on real time continuous glucose monitoring:the DirecNet navigator pilot study experience [J].Diabetes Educ,2009,35(1):124-135.DOI:10.1177/0145721708325157.
[10] 侯新国.血糖监测从点到曲线的路,我们有哪些误区 [J].中华糖尿病杂志,2019,11(8):562-564.DOI:10.3760/cma.j.issn.1674-5809.2019.08.012.
[11] Rebrin K,Sheppard NF Jr,Steil GM.Use of subcutaneous interstitial fluid glucose to estimate blood glucose:revisiting delay and sensor offset [J].J Diabetes Sci Technol,2010,4(5):1087-1098.DOI:10.1177/193229681000400507.
[12] Cobelli C,Schiavon M,Dalla Man C,et al.Interstitial fluid glucose is not just a shifted-in-time but a distorted mirror of blood glucose:insight from an in silico study [J].Diabetes Technol Ther,2016,18(8):505-511.DOI:10.1089/dia.2016.0112.
[13] Bergenstal RM,Klonoff DC,Garg SK,et al.Threshold-based insulin-pump interruption for reduction of hypoglycemia [J].N Engl J Med,2013,369(3):224-232.DOI:10.1056/NEJMoa1303576.
[14] Danne T,Nimri R,Battelino T,et al.International consensus on use of continuous glucose monitoring [J].Diabetes Care,2017,40(12):1631-1640.DOI:10.2337/dc17-1600.
[15] American Diabetes Association.6.Glycemic targets:standards of medical care in diabetes-2020 [J].Diabetes Care,2020,43(Suppl 1):S66-S76.DOI:10.2337/dc20-S006.
[16] 刘斌.2019CDS中华医学会血糖监测年会赵晓龙教授提出控糖三角理论,提倡糖尿病患者建立个性化控糖方案 [EB/OL].[2019-12-11].http://nb.ifeng.com/a/20191211/7852233_0.shtml.
[17] 赵晓龙,孙全娅.扫描式葡萄糖监测在胰岛素泵疗法中的应用 [J].中华糖尿病杂志,2019,11(6):437-440.DOI:10.3760/cma.j.issn.1674-5809.2019.06.013.
[18] Kohnert KD,Augstein P,Heinke P,et al.Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes [J].Diabetes Res Clin Pract,2007,77(3):420-426.DOI:10.1016/j.diabres.2007.01.021.
[19] Ajjan RA,Cummings MH,Jennings P,et al.Optimising use of rate-of-change trend arrows for insulin dosing decisions using the FreeStyle Libre flash glucose monitoring system [J].Diab Vasc Dis Res,2019,16(1):3-12.DOI:10.1177/1479164118795252.
[20] 时健英,张秋梅,赵盈,等.手机医疗软件改善2型糖尿病患者血糖控制的研究 [J].国际内分泌代谢杂志,2019,39(1):17-20.DOI:10.3760/cma.j.issn.1673-4157.2019.01.004.
[21] Bratcher CR,Bello E.Traditional or centralized models of diabetes care:the multidisciplinary diabetes team approach [J].J Fam Pract,2011,60(11 Suppl):S6-11.
[22] Nettles A,Belton A.An overview of training curricula for diabetes peer educators [J].Fam Pract,2010,27(Suppl ):i33-39.DOI:10.1093/fampra/cmn102.
[23] Egger G,Stevens J,Ganora C,et al.Programmed shared medical appointments:A novel procedure for chronic disease management [J].Aust J Gen Pract,2018,47(1-2):70-75.DOI:10.31128/afp-07-17-4283.
[24] Dankwa-Mullan I,Rivo M,Sepulveda M,et al.Transforming diabetes care through artificial intelligence:the future is here [J].Popul Health Manag,2019,22(3):229-242.DOI:10.1089/pop.2018.0129.
[25] 刘蔚,纪立农.从循证证据看扫描式葡萄糖监测技术的应用 [J].中华糖尿病杂志,2018,10(10):637-639.DOI:10.3760/cma.j.issn.1674-5809.2018.10.002.

相似文献/References:

[1]赵紫琴,雒瑢,田凤石,等.替米沙坦对OLETF大鼠皮下和内脏脂肪组织PPARγ表达的影响[J].国际内分泌代谢杂志,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
　Zhao Ziqin*,Luo Rong,Tian Fengshi,et al.Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats[J].International Journal of Endocrinology and Metabolism,2014,(04):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
[2]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
　Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(04):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[3]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
　Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(04):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[4]刘艳 田秀标 韩颖.GLP-1受体激动剂呈葡萄糖依赖性刺激胰岛β细胞胰岛素分泌的机制[J].国际内分泌代谢杂志,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
　Liu Yan*,Tian Xiubiao,Han Ying..Mechanism of GLP-1 receptor agonists in the stimulation of insulin secretion of islet β cell in a glucose-dependent manner[J].International Journal of Endocrinology and Metabolism,2015,(04):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
[5]齐利琴,刘礼斌.GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用[J].国际内分泌代谢杂志,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
　Qi Liqin,Liu Libin..Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(04):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
[6]梅稳,向光大,卢俊颜,等.GDF11对ApoE-/-糖尿病小鼠内皮依赖性 血管舒张功能的作用[J].国际内分泌代谢杂志,2016,36(02):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
　Mei Wen*,Xiang Guangda,Lu Junyan,et al.Effects of GDF11 on endothelium-dependent vasodiation function of aorta in ApoE-/- diabetic mice[J].International Journal of Endocrinology and Metabolism,2016,36(04):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
[7]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白 与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
　Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(04):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[8]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平 及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
　Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[9]陈双双,王楚媛,孔令芳.铬与2型糖尿病[J].国际内分泌代谢杂志,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
　Chen Shuangshuang,Wang Chuyuan,Kong Lingfang.Chromium and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
[10]涂萍,许婷,段鹏,等.25-羟维生素D3补充对绝经后2型糖尿病 患者胰岛素敏感性及血糖控制的影响[J].国际内分泌代谢杂志,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
　Tu Ping,Xu Ting,Duan Peng,et al.Influence of 25-hydroxyvitamin D3 supplement on insulin sensitivity and glucose control in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(04):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81770776,82073909); 山西省回国留学人员科研资助项目(2020-172); 山西省研究生教育创新项目(2020SY258)
通信作者:刘云峰,Email:nectarliu@163.com
更新日期/Last Update: 1900-01-01